company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7899000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7899000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1021000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,12000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-54000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6914000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6914000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1898000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1898000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1898000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,634000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7044000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7044000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1005000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5839000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5839000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2949000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2948000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2948000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1432000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,2000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,33750000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11251000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21069000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21069000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,584000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,990000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1221000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,972000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2605000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3987000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3987000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-832000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-832000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-832000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38016000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38017000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38017000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33198000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1175000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8762000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8762000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1011000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,91000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-341000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2922000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10923000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10923000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1203000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19755000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-38016000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,38016000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31881000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1185000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1029000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,199000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-98000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-116000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8494000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8494000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1649000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-916000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2565000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2565000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11048000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1213000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15283000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15283000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1284000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,48000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5252000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1103000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7596000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7596000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2483000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52619000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,14000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22649000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,20671000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11768000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11768000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87022000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37892000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49130000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49130000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29766000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1166000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1380000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,47000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,619000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7697000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17545000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17545000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2901000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,371000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2530000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2530000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-880000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-880000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-880000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20955000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1168000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1405000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,147000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2194000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15679000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20229000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20229000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4366000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32772000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10404000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47542000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47542000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62855000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1263000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,64003000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,64003000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3768000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1114000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-6987000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,199000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,407000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10949000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11177000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11177000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6258000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,4566000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-117000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1809000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1809000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,250000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,250000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,250000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1008000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9850000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,199000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2619000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17501000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21179000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21179000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4732000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25841000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53120000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-189000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22359000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22359000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,237000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,237000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1417000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,939000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23138000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23138000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1431000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,949000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5623000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13789000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13789000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2932000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18750000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-72069000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56251000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56251000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34691000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,120877000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86186000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86186000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16146000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,584000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1286000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2225000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3978000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1740000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-87220000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12050000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,71387000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5523000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5523000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1187000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1187000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1187000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17646000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,262000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1330000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1155000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3808000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1315000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9837000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9837000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4696000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23764000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-559000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3615000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3615000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,120000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-119021000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,979000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,979000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5243000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2311000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1700000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3287000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-468000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6280000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6280000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3426000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12185000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-790000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14599000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14599000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9132000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,343000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2603000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3983000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1002000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3808000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18946000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32772000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-999000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9019000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9019000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1964000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1964000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1964000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6247000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2251000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:39:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2333000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1155000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5686000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4081000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8218000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8218000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6023000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47527000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24169000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1193000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30574000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30574000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,110407000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1387000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,111794000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,111794000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,89438000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,332000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2392000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7687000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,128000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8360000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8360000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4330000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98402000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11075000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9528000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-101185000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-101185000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-90444000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2290000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5802000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5802000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2707000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7624000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2568000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14722000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14722000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8823000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,572000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12270000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1713000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2306000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2306000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1229000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1507000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19764000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7517000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13547000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-870000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-870000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7874000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49937000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59631000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1620000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4047000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4047000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4047000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3377000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2297000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,160000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2783000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1142000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7347000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4102000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7178000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7178000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11832000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42984000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38548000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1742000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18010000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18010000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1466000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1195000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2928000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2657000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2657000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8175000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4719000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4719000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11506000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32276000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36805000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1765000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8742000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8742000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1823000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1823000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1823000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1927000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,40000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3119000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1142000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9686000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5496000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16994000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16994000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9083000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63885000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82256000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1992000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,898000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1275000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2172000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2172000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26462000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3854000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3854000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3165000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1142000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8490000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12064000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3121000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3121000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7053000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67843000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54925000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1904000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21875000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21875000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3041000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3041000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3041000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21955000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1926000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,142000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3216000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1142000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7665000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3476000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7541000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7541000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8868000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53947000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45140000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1967000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19642000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19642000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,995000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1390000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2389000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9720000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,99000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22165000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22165000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3278000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1141000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7361000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22069000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11684000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11684000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3906000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37105000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9919000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,769000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,769000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,769000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-867000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1926000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19866000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19866000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3104000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1579000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11258000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3931000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3616000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-180342000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42214000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2092000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-143836000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-143836000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-128712000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,345000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,568000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,216856000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,216856000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73026000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2380000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3709000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3307000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9248000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7135000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3656000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3656000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5155000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94449000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40568000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2114000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61150000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61150000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-479000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1056000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1761000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2338000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2338000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55156000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,133000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3361000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3363000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8772000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10707000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2808000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2808000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5419000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-161226000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,141180000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2013000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27478000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27478000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2690000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2688000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2688000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27598000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4512000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4595000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4595000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3659000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3422000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8188000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2933000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16931000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16931000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5076000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66735000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97751000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2241000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8699000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8699000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,806000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1474000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2280000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2280000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27910000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10680000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10680000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2762000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3504000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8395000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6670000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2689000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2689000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5184000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-130580000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,127764000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2293000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10293000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10293000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,419000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,419000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,419000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12563000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4102000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2564000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2564000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2848000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3565000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7047000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2314000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13710000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13710000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2634000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52169000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116798000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2422000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,59573000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,59573000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,952000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1073000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2025000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2025000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75308000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,146000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3504000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3629000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8961000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1175000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16629000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16629000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4453000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101040000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2127000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,94459000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,94459000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2982000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2982000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2982000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,114070000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4051000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3691000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8241000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3048000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21220000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21220000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2243000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-180505000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59586000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-123163000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-123163000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,832000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2696000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3528000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3528000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-98415000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4097000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-18000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3765000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7434000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8529000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3499000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3499000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2018000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22688000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,103187000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,78481000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,78481000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-338000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,868000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,530000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,530000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,82510000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2730000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2730000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5281000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3828000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7940000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2984000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2052000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-120305000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119272000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59830000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-181799000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-181799000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1270000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2467000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3737000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3737000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-155299000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4097000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,490000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6087000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6087000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5605000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3896000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14042000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,898000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18354000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18354000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1592000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-78131000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,85348000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5625000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5625000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1423000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1423000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1423000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25402000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,212000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4888000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4888000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5090000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3964000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9189000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12549000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25904000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25904000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4497000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,992000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98393000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71103000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30795000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30795000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1132000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3152000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2020000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2020000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6911000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4097000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,161000.0
